These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31529613)

  • 21. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticonvulsant activity of four oxygenated cannabidiol derivatives.
    Carlini EA; Mechoulam R; Lander N
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):1-15. PubMed ID: 1188178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of a primary metabolite of cannabidiol.
    Tchilibon S; Mechoulam R
    Org Lett; 2000 Oct; 2(21):3301-3. PubMed ID: 11029195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiepileptic potential of cannabidiol analogs.
    Consroe P; Martin A; Singh V
    J Clin Pharmacol; 1981; 21(S1):428S-436S. PubMed ID: 7298873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutraceutical potential of industrial hemp (
    Zheng H; Chen B; Rao J
    Food Funct; 2022 Apr; 13(8):4502-4512. PubMed ID: 35348145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
    Morini L; Porro G; Liso M; Groppi A
    Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB
    Navarro G; Gonzalez A; Sánchez-Morales A; Casajuana-Martin N; Gómez-Ventura M; Cordomí A; Busqué F; Alibés R; Pardo L; Franco R
    J Med Chem; 2021 Jul; 64(13):9354-9364. PubMed ID: 34161090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters.
    Aparicio-Blanco J; Sebastián V; Benoit JP; Torres-Suárez AI
    Eur J Pharm Biopharm; 2019 Jan; 134():126-137. PubMed ID: 30472144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Methods for the Comprehensive Analysis of Bioactive Compounds in
    Pellati F; Brighenti V; Sperlea J; Marchetti L; Bertelli D; Benvenuti S
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30322208
    [No Abstract]   [Full Text] [Related]  

  • 33. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
    Schier AR; Ribeiro NP; Silva AC; Hallak JE; Crippa JA; Nardi AE; Zuardi AW
    Braz J Psychiatry; 2012 Jun; 34 Suppl 1():S104-10. PubMed ID: 22729452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.
    Yamaori S; Okamoto Y; Yamamoto I; Watanabe K
    Drug Metab Dispos; 2011 Nov; 39(11):2049-56. PubMed ID: 21821735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological Aspects of Medical Use of Cannabidiol.
    Mannucci C; Navarra M; Calapai F; Spagnolo EV; Busardò FP; Cas RD; Ippolito FM; Calapai G
    CNS Neurol Disord Drug Targets; 2017; 16(5):541-553. PubMed ID: 28412918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trends on cannabidiol delivery systems: where are we and where are we going?
    Ramalho ÍMM; Pereira DT; Galvão GBL; Freire DT; Amaral-Machado L; Alencar ÉDN; Egito ESTD
    Expert Opin Drug Deliv; 2021 Nov; 18(11):1577-1587. PubMed ID: 34253133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils.
    Kitamura M; Kiba Y; Suzuki R; Tomida N; Uwaya A; Isami F; Deng S
    Medicines (Basel); 2020 Sep; 7(9):. PubMed ID: 32906708
    [No Abstract]   [Full Text] [Related]  

  • 38. The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne.
    Peyravian N; Deo S; Daunert S; Jimenez JJ
    J Inflamm Res; 2022; 15():2795-2801. PubMed ID: 35535052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and β.
    Wilson JT; Fief CA; Jackson KD; Mercer SL; Deweese JE
    Chem Res Toxicol; 2018 Feb; 31(2):137-144. PubMed ID: 29272108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemp in Animal Diets-Cannabidiol.
    Fallahi S; Bobak Ł; Opaliński S
    Animals (Basel); 2022 Sep; 12(19):. PubMed ID: 36230282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.